IDiyas

For the Inventor, By the Inventor

Grayslake, IL, United States of America

John N Simons

USPTO Granted Patents = 11

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 107(Granted Patents)


Company Filing History:

goldMedal11 out of 4,177 
 
Abbott Laboratories Corporation
 patents

Years Active: 1998-2004

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6720166 - Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use (2004-04-13),
2. 6586568 - Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use (2003-07-01),
3. 6558898 - Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use (2003-05-06),
4. 6451578 - Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use (2002-09-17),
5. 6395472 - Methods of utilizing the TT virus (2002-05-28),
6. 6156495 - Hepatitis GB virus recombinant proteins and uses thereof (2000-12-05),
7. 6051374 - Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for (2000-04-18),
8. 5981172 - Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for (1999-11-09),
9. 5955318 - Reagents and methods useful for controlling the translation of hepatitis (1999-09-21),
10. 5807670 - Detection of hepatitis GB virus genotypes (1998-09-15),
11. 5709997 - Nucleic acid detection of hepatitis GB virus (1998-01-20),

Title: Innovations of John N Simons

Introduction

John N Simons is a prominent inventor based in Grayslake, IL (US). He has made significant contributions to the field of medical diagnostics and therapeutics, holding a total of 11 patents. His work primarily focuses on hepatitis reagents and methods that have important implications for healthcare.

Latest Patents

Among his latest patents are innovations related to Non-A, Non-B, Non-C, Non-D, and Non-E hepatitis reagents. These patents include the Hepatitis GB Virus (HGBV) nucleic acid and amino acid sequences, which are useful for a variety of diagnostic and therapeutic applications. Additionally, he has developed kits for using the HGBV nucleic acid or amino acid sequences, HGBV immunogenic particles, and antibodies that specifically bind to HGBV. His patents also provide methods for producing antibodies, whether polyclonal or monoclonal, from the HGBV nucleic acid or amino acid sequences.

Career Highlights

John N Simons is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that address critical health issues related to hepatitis.

Collaborations

Throughout his career, John has collaborated with notable colleagues, including Suresh M Desai and Isa K Mushahwar. These collaborations have further enhanced the impact of his inventions in the medical field.

Conclusion

John N Simons exemplifies the spirit of innovation in the medical industry through his extensive patent portfolio and collaborative efforts. His contributions continue to advance the understanding and treatment of hepatitis, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…